ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThis study tests a new drug (HRS-4642) combined with an immunotherapy (adebrelimab) and possibly other cancer drugs for people with advanced pancreatic cancer that has not responded to standard treatments. The goal is to find safe doses and see if the combination can shrink tumor…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug candidate BL-M05D1 enters early human trials for tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called BL-M05D1 in people with advanced or metastatic solid tumors (like stomach, pancreatic, or bile duct cancer) that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug c…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Nano drug aims to boost appetite and weight in pancreatic cancer patients
Symptom relief Recruiting nowThis study tests a new nano-formulation of megestrol acetate, a drug used to stimulate appetite and promote weight gain, in patients with advanced pancreatic cancer who suffer from anorexia-cachexia syndrome. The trial will enroll 56 patients and compare those receiving the nano-…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: Shandong Cancer Hospital and Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Pancreatic cancer registry launches to map Real-World treatment outcomes
Knowledge-focused Recruiting nowThis registry is collecting information from 1,500 people with advanced pancreatic cancer in Austria to see how different chemotherapy treatments work in everyday practice. Researchers will track which treatments are used, how well they work, and what side effects occur. The goal…
Matched conditions: ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC